首页 > 过刊浏览>2019年第19卷第11期 >2019,19(11):1888-1891. DOI:10.3980/j.issn.1672-5123.2019.11.17
上一篇 | 下一篇

视网膜静脉阻塞继发黄斑水肿发病机制及黄斑水肿影响视功能的研究进展

Research progress on the pathogenesis of macular edema secondary to retinal vein occlusion and the effect of macular edema on visual function

发布日期：2019-10-23
  • 摘要
  • 访问统计
  • PDF预览
  • 参考文献
  • 相似文献
  • 引证文献
    [关键词]
    [摘要]

    视网膜静脉阻塞(RVO)是一种常见的视网膜血管疾病，其继发的黄斑水肿(ME)是引起患者视力下降的主要原因。RVO继发ME的发病机制复杂，目前尚未充分阐明，有许多细胞和细胞因子参与其中，使进入和转出视网膜液体之间的平衡被打乱，进而形成ME。本文就RVO继发ME的发病机制以及ME影响视功能的机制展开综述。

    [Key word]
    [Abstract]
    Retinal vein occlusion(RVO)is a common retinal vascular disease. Macular edema(ME)secondary to RVO is the main cause of visual impairment in patients. The mechanisms of ME secondary to RVO are intricate and have not yet been fully elucidated. Many cells and cytokines are involved in it, which disrupt the balance between fluid entry and exit in the retina. This review discusses the complex pathogenesis of ME associated with RVO and the mechanisms by which ME affects visual function.
    1 Li J, Paulus YM, Shuai Y,et al. New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion. J Ophthalmol 2017; 2017:4936924
    2 Daruich A, Matet A, Moulin A, et al. Mechanisms of macular edema: Beyond the surface. Prog Retin Eye Res 2018; 63:20-68
    3 Cunha-Vaz JG. The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res 2004; 78(3):715-721
    4 Yao H, Wang T, Deng J, et al. The development of blood-retinal barrier during the interaction of astrocytes with vascular wall cells. Neural Regen Res 2014; 9(10):1047-1054
    5 Díaz-Coránguez M, Ramos C, Antonetti DA. The inner blood-retinal barrier: Cellular basis and development. Vision Res 2017; 139:123-137
    6 Klaassen I, Van Noorden CJF, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 2013; 34:19-48
    7 Peng S, Gan G, Qiu C, et al. Engineering a blood-retinal barrier with human embryonic stem cell-derived retinal pigment epithelium: transcriptome and functional analysis. Stem Cells Transl Med 2013; 2(7):534-544
    8 Obert E, Strauss R, Brandon C, et al. Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology. J Mol Med(Berl) 2017; 95(5):535-552
    9 Wortzel I, Seger R. The ERK Cascade: Distinct Functions within Various Subcellular Organelles. Genes Cancer 2011; 2(3):195-209
    10 Cunha-Vaz J. The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture. Ophthalmologica 2017; 237(1):1-10
    11 Andreadi C, Noble C, Patel B, et al. Regulation of MEK/ERK pathway output by subcellular localization of B-Raf. Biochem Soc Trans 2012; 40(1):67-72
    12 Gallina D, Zelinka CP, Cebulla CM, et al. Activation of glucocorticoid receptors in Müller glia is protective to retinal neurons and suppresses microglial reactivity. Exp Neurol 2015; 273:114-125
    13 Qi Y, Zhao M, Bai Y, et al. Retinal ischemia/reperfusion injury is mediated by Toll like receptor 4 activation of NLRP3 inflammasomes. Invest Ophthalmol Vis Sci 2014:55(9):5466-5475
    14 Kirkley KS, Popichak KA, Afzali MF, et al. Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity. J Neuroinflammation 2017; 14(1):99
    15 Fernández-Robredo P, Selvam S, Powner MB, et al. Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation. PLoS One 2017; 12(1):e0169865
    16 Ellenberg D, Azar DT, Hallak JA, et al. Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res 2010; 29(3):208-248
    17 Wang S, Ji LY, Li L, et al. Oxidative stress, autophagy and pyroptosis in the neovascularization of oxygen induced retinopathy in mice. Mol Med Rep 2018; 19(2):927-934
    18 Thorell MR, Goldhardt R. Update in the Management of Macular Edema Following Retinal Vein Occlusions. Curr Ophthalmol Rep 2016; 4(1):38-47
    19 Noma H, Funatsu H, Mimura T, et al.Increase of vascular endothelial growth factor and interleukin 6 in the aqueous humour of patients with macularo edema and central retinal vein occlusion. Acta Ophthalmol 2009; 88(6):646-651
    20 Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res 2015; 49:67-81
    21 Xia JP, Wang S, Zhang JS. The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion. Biochem Biophys Res Commun 2019; 508(4):1264-1270
    22 Cachafeiro M, Bemelmans AP, Samardzija M, et al. Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability. Cell Death Dis 2013; 4(8):e781
    23 Jung SH, Kim KA, Sohn SW, et al. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion. Invest Ophthalmol Vis Sci 2014; 55(4):2290-2296
    24 Zittermann SI, Issekutz AC. Basic fibroblast growth factor(bFGF, FGF-2)potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 2006; 168:835-846
    25 Feng J, Zhao T, Zhang Y, et al. Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion. PLoS One 2013; 8(7):e68149
    26 Tuuminen R, Loukovaara S. High intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusion. Eye(Lond) 2014; 28(9):1095-1099
    27 Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cvtokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 2009; 50(3):1025-1032
    28 Deobhakta A, Chang LK. Inflammation in retinal vein occlusion. Int J Inflam 2013; 2013(1):438412
    29 Ascaso FJ, Huerva V, Grzybowski A. The Role of Inflammation in the Pathogenesis of Macular Edema Secondary to Retinal Vascular Diseases. Mediators Inflamm 2014; 2014:1-6
    30 Peng J, He F, Zhang C, et al. Protein kinase C-α signals P115RhoGEF phosphorylation and RhoA activation in TNF-α-induced mouse brain microvascular endothelial cell barrier dysfunction. J Neuroinflammation 2011; 8(1):1-10
    31 Noma H, Funatsu H, Mimura T. Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion. J Ocul Pharmacol Ther 2013; 29(3):363-365
    32 Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009; 4(12):e8158
    33 Fonollosa A, Garciaarumi J, Santos E, et al. Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular edema with branch retinal vein occlusion. Eye 2010; 24(7):1284-1290
    34 Bringmann A, Pannicke T, Grosche J, et al. Müller cells in the healthy and diseasedretina. Prog Retin Eye Res 2006; 25:397-424
    35 Pannicke T, Ivo Chao T, Reisenhofer M, et al. Comparative electrophysiology of retinal Müller glial cells-A survey on vertebrate species. Glia 2017; 65(4):533-568
    36 Reichenbach A, Wurm A, Pannicke T. Müller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol 2007; 245(5):627-636
    37 Baetz NW, Stamer WD, Yool AJ. Stimulation of aquaporin-mediated fluid transport by cyclic GMP in human retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci 2012; 53(4):2127-2132
    38 Yu J, Chen C, Wang J, et al. In vitro effect of adenosine on the mRNA expression of Kir 2.1 and Kir 4.1 channels in rat retinal Müller cells at elevated hydrostatic pressure. Exp Ther Med 2012; 3(4):617-620
    39 Rizzolo LJ, Chen X, Weitzman M, et al. Analysis of the RPE transcriptome reveals dynamic changes during the development of the outer blood-retinal barrier. Mol Vis 2007; 13:1259-1273
    40 Baetz NW, Stamer WD, Yool AJ. Stimulation of aquaporin-mediated fluid transport by cyclic GMP in human retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci 2012; 53(4):2127-2132
    41 Ota T, Tsujikawa A, Murakami T, et al. Subfoveal serous retinal detachment associated with extramacular branch retinal vein occlusion. Clin Ophthalmol 2013; 7:237-241
    42 Celık E, Do(ˇoverg)an E, Turkoglu EB, et al. Serous retinal detachment in patients with macular edema secondary to branch retinal vein occlusion. Arq Bras Oftalmol 2016; 79(1):9-11
    43 Muraoka Y, Tsujikawa A, Murakami T, et al. Branch retinal vein occlusion-associated subretinal hemorrhage. Jpn J Ophthalmol 2013; 57:275-282
    44 Muraoka Y, Tsujikawa A, Takahashi A, et al. Foveal damage due to subfoveal hemorrhage associated with branch retinal vein occlusion. PLoS One 2015; 10:e0144894
    45 Chatziralli I, Theodossiadis G, Chatzirallis A, et al. Ranibizumab for retinal vein occlusion: Predictive Factors and Long-Term Outcomes in Real-Life Data. Retina 2018; 38(3):559-568
    46 Liu H, Li S, Zhang Z, et al. Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure. Exp Ther Med 2018; 15(1):890-896
    47 Kang HM, Chung EJ, Kim YM, et al. Spectral-domain optical coherence tomography(SD-OCT)patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2013; 251(2):501-508
    48 Ota M, Tsujikawa A, Kita M, et al. Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 2008; 28(10):1502-1508
    49 Khayat M, Williams M, Lois N. Ischemic Retinal Vein Occlusion: characterizing the more severe spectrum of retinal vein occlusion. Surv Ophthalmol 2018; 63(6):816-850
    50 Iijima H. Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion. Jpn J Ophthalmol 2018; 62(3):265-273
    51 Jumper JM, Dugel PU, Chen S, et al. Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice(ECHO study report 2). Clin Ophthalmol 2018; 12:621-629
    52 Bhisitkul RB, Campochiaro PA, Shapiro H, et al. Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology 2013; 120(5):1057-1063
您是第 8394447 位访问者
主管单位：陕西省卫生健康委员会
主办单位：中华医学会西安分会
地址：陕西省西安市碑林区雁塔路北段8号万达广场2栋1单元11707室
传真：029-82245172 电话：029-85205906/82245172
Email：ijo.2000@163.com,ijo2000@126.com
国际眼科杂志 ® 2025 版权所有   CC BY-NC-ND 4.0 适用于所有开放获取内容